23andMe’s second act sits squarely in drug research and development

0

 The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders from the Food and Drug Administration that 23andMe cease sales of its consumer health report product, which drove a major portion of both 23andMe’s revenue and brand awareness at the… Read More

Source link

We will be happy to hear your thoughts

Leave a reply

Big Money Coach
Big Money Coach
Register New Account
Name (required)

Reset Password
Skip to toolbar